title: Nuclear factor-kappaB p50 subunits in chronic periodontitis and Porphyromonas gingivalis lipopolysaccharide-pulsed dendritic cells.
abstract: The pathogenesis of a number of chronic inflammatory diseases has been linked to dysregulated functioning of nuclear transcription factor (NF)-kappaB. In the present study, we examine NF-kappaB activation in human oral mucosal tissues of chronic periodontitis (CP) patients. Electrophoretic mobility shift assay and DNA-binding enzyme-linked immunosorbent assays indicate elevated levels of transcriptionally repressive p50 subunits and an increased p50/p65 ratio in CP tissues compared to healthy controls. Because Porphyromonas gingivalis has been recognized to be a causal factor in CP, we used P. gingivalis lipopolysaccharide (LPS) for in vitro studies with monocyte-derived dendritic cells (MoDCs). Porphyromonas gingivalis LPS, unlike Escherichia coli LPS, induced an increased p50/p65 ratio in MoDCs. Using blocking antibodies, we demonstrated that while both Toll-like receptor 2 (TLR2) and TLR4 are required for MoDC maturation by P. gingivalis LPS, only TLR4 signaling is sufficient to induce cytokine secretion. Our results suggest that increased levels of transcriptionally repressive p50 may be characteristic of CP and might be a result of suboptimal NF-kappaB activation and dendritic cell maturation by P. gingivalis, a bacterium implicated in CP.
authors.affiliation: Department of Periodontics and Implantology, Stony Brook University School of Dental Medicine, Stony Brook, NY, USA.
authors.forename: Ravi
authors.initials: R
authors.lastname: Jotwani
authors.forename: Baljit S
authors.initials: BS
authors.lastname: Moonga
authors.forename: Siddharth
authors.initials: S
authors.lastname: Gupta
authors.forename: Christopher W
authors.initials: CW
authors.lastname: Cutler
mesh_terms: D016866:Bacteroidaceae Infections / Q000276:immunology / Q000378:metabolism; D016022:Case-Control Studies; D002478:Cells, Cultured; D055113:Chronic Periodontitis / Q000276:immunology / Q000378:metabolism*; D003713:Dendritic Cells / Q000187:drug effects* / Q000378:metabolism*; D006801:Humans; D053583:Interleukin-1beta / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008070:Lipopolysaccharides / Q000302:isolation & purification / Q000494:pharmacology*; D052002:NF-kappa B p50 Subunit / Q000276:immunology / Q000378:metabolism*; D016966:Porphyromonas gingivalis / Q000737:chemistry; D011673:Pulsatile Flow / Q000187:drug effects / Q000502:physiology; D051193:Toll-Like Receptors / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D053583:Interleukin-1beta; D015850:Interleukin-6; D008070:Lipopolysaccharides; D052002:NF-kappa B p50 Subunit; D051193:Toll-Like Receptors; D014409:Tumor Necrosis Factor-alpha
references.citation: J Clin Invest. 1998 Nov 1;102(9):1645-52
references.pmid: 9802878
references.citation: Immunity. 2002 Feb;16(2):257-70
references.pmid: 11869686
references.citation: Science. 2007 Aug 3;317(5838):675-8
references.pmid: 17673665
references.citation: Mol Cell Biol. 2004 Jul;24(14):6488-500
references.pmid: 15226448
references.citation: J Immunol. 2001 Oct 15;167(8):4693-700
references.pmid: 11591800
references.citation: Periodontol 2000. 2006;40:130-43
references.pmid: 16398690
references.citation: Front Biosci. 2007 May 01;12:3795-812
references.pmid: 17485340
references.citation: Eur J Immunol. 2003 Nov;33(11):2980-6
references.pmid: 14579266
references.citation: Front Biosci. 2008 Jan 01;13:2041-59
references.pmid: 17981690
references.citation: Infect Immun. 2005 Feb;73(2):687-94
references.pmid: 15664906
references.citation: Infect Immun. 1996 Jun;64(6):2282-7
references.pmid: 8675338
references.citation: Annu Rev Immunol. 1996;14:649-83
references.pmid: 8717528